VXB-211

N/A

Report date: 2023/06/26 09:15:25

Base Information

Drug NameVXB-211
Drug Alias NameVXB-211
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVicebio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVicebio Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A